Dr. Jeffrey R. Jay, M.D. »

Disc Medicine shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2025-12-31 $20M 250k 79.41

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Amylyx Pharmaceuticals (AMLX)
Zura Bio Class A Ord Shs (ZURA)
Disc Medicine (IRON)
Rapt Therapeutics Com New (RAPT)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Vor Biopharma Com New (VOR)
Dianthus Therapeutics (DNTH)
Jade Biosciences Com New (JBIO)
Kalvista Pharmaceuticals (KALV)
Contineum Therapeutics Cl A (CTNM)
Eupraxia Pharmaceuticals (EPRX)
Fulcrum Therapeutics (FULC)
Nektar Therapeutics Com New (NKTR)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Disc Medicine

FMR
Atlas Venture Life Science Advisors
BlackRock
Vanguard Group
RA Capital Management
Frazier Life Sciences Management
OrbiMed Advisors
Wellington Management Company
State Street Corporation
Woodline Partners
Siren
Goldman Sachs Group
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates

View all funds holding Disc Medicine